Immediate Impact

1 by Nobel laureates 1 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
3 intermediate papers

Works of Mary Guckert being referenced

Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma.
2014
Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Mary Guckert 505 50 461 143 18 801
Swarupa G. Kulkarni 503 52 292 29 17 745
Michael P. Sheets 575 161 150 67 22 953
Julie C. Lougheed 564 63 249 33 16 972
Sarah Beck 523 17 195 249 30 985
Olivia Gardner 660 49 400 29 22 913
Sujatha Nallapareddy 506 48 439 34 16 781
Bogusława Karaszewska 304 28 657 84 28 926
Rosemary C. McFall 368 236 166 65 23 869
Gengjie Yang 285 84 288 81 21 803
Danny Tam 443 119 140 58 25 857

All Works

Loading papers...

Rankless by CCL
2026